Kaushal K, Thummar V, Mehta P. Real-World Evaluation of Trastuzumab Emtansine Biosimilar in Early-Stage HER2-Positive Breast Cancer: Results from a Single-Center Retrospective Study in India: Real-world outcomes of T-DM1 biosimilar. Arch Breast Cancer [Internet]. 2026 Apr. 22 [cited 2026 May 26];13(2):182-9. Available from: https://www.archbreastcancer.com/index.php/abc/article/view/1241